Experts Urge Action On Regulatory Science Collaboration In Korea

Sponsors Need To 'Educate' Regulator

Experts discussed regulatory science issues at a recent forum in South Korea, including the responsibilities of sponsors and regulators as well as the need to strengthen collaborations and accelerate the development of innovative drugs and converged medical products.

accelerating development
Experts Suggest Korea's MFDS Has Been 'Excessive' In Duties • Source: Shutterstock

As South Korea moves forward with regulatory science innovation in line with the rapid development of cutting-edge medicines and medical products, there is a growing need for collaboration between the national regulatory agency, sponsors and academia to shape future regulations for such innovative products and accelerate their development. 

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from South Korea

More from Asia